Prescient Therapeutics Limited (PTX.AX)
AUD 0.05
(4.26%)
AUD 0.05
(4.26%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 3.71 Million AUD | 52.89% |
| 2023 | 2.42 Million AUD | 28.52% |
| 2022 | 1.88 Million AUD | 59.37% |
| 2021 | 1.18 Million AUD | 15.17% |
| 2020 | 1.02 Million AUD | -37.53% |
| 2019 | 1.64 Million AUD | 75.34% |
| 2018 | 939.77 Thousand AUD | -23.24% |
| 2017 | 1.22 Million AUD | 22.12% |
| 2016 | 1 Million AUD | 299.27% |
| 2015 | 251.08 Thousand AUD | 2983.82% |
| 2014 | 8142.00 AUD | 0.0% |
| 2013 | - AUD | 0.0% |
| 2012 | - AUD | 0.0% |
| 2011 | - AUD | 0.0% |
| 2010 | - AUD | 0.0% |
| 2009 | - AUD | -100.0% |
| 2008 | 521 Thousand AUD | -85.25% |
| 2007 | 3.53 Million AUD | 1589.95% |
| 2006 | 209 Thousand AUD | -85.28% |
| 2005 | 1.42 Million AUD | 0.0% |
| 2004 | - AUD | -100.0% |
| 2003 | 323 Thousand AUD | -25.75% |
| 2002 | 435 Thousand AUD | 0.0% |
| 2001 | - AUD | 0.0% |
| 2000 | - AUD | 0.0% |
| 1999 | - AUD | 0.0% |
| 1998 | - AUD | 0.0% |
| 1997 | - AUD | 0.0% |
| 1996 | - AUD | 0.0% |
| 1995 | - AUD | 0.0% |
| 1994 | - AUD | 0.0% |
| 1993 | - AUD | 0.0% |
| 1992 | - AUD | 0.0% |
| 1991 | - AUD | 0.0% |
| 1990 | - AUD | 0.0% |
| 1989 | - AUD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 FY | - AUD | -100.0% |
| 2024 Q4 | 1.77 Million AUD | 0.0% |
| 2024 Q2 | 1.93 Million AUD | 0.0% |
| 2023 Q2 | 1.25 Million AUD | 0.0% |
| 2023 FY | 2.42 Million AUD | 28.52% |
| 2023 Q4 | 1.17 Million AUD | 0.0% |
| 2022 FY | 1.88 Million AUD | 59.37% |
| 2022 Q4 | 1.04 Million AUD | 0.0% |
| 2022 Q2 | 842.48 Thousand AUD | 0.0% |
| 2021 Q4 | 537.62 Thousand AUD | 0.0% |
| 2021 FY | 1.18 Million AUD | 15.17% |
| 2021 Q2 | 647.85 Thousand AUD | 0.0% |
| 2020 Q4 | 430.21 Thousand AUD | 0.0% |
| 2020 FY | 1.02 Million AUD | -37.53% |
| 2020 Q2 | 599.12 Thousand AUD | 0.0% |
| 2019 FY | 1.64 Million AUD | 75.34% |
| 2019 Q4 | 937.14 Thousand AUD | 0.0% |
| 2019 Q2 | 710.61 Thousand AUD | 0.0% |
| 2018 Q2 | 456.69 Thousand AUD | 0.0% |
| 2018 Q4 | 483.08 Thousand AUD | 0.0% |
| 2018 FY | 939.77 Thousand AUD | -23.24% |
| 2017 Q4 | 660.82 Thousand AUD | 0.0% |
| 2017 FY | 1.22 Million AUD | 22.12% |
| 2017 Q2 | 563.42 Thousand AUD | 0.0% |
| 2016 Q4 | 290.55 Thousand AUD | 0.0% |
| 2016 Q2 | 711.94 Thousand AUD | 0.0% |
| 2016 FY | 1 Million AUD | 299.27% |
| 2015 Q4 | 219.94 Thousand AUD | 0.0% |
| 2015 FY | 251.08 Thousand AUD | 2983.82% |
| 2015 Q2 | 31.14 Thousand AUD | 0.0% |
| 2014 Q4 | 7994.00 AUD | 0.0% |
| 2014 Q2 | 148.00 AUD | 0.0% |
| 2014 FY | 8142.00 AUD | 0.0% |
| 2013 Q4 | - AUD | 0.0% |
| 2013 Q3 | - AUD | 0.0% |
| 2013 FY | - AUD | 0.0% |
| 2013 Q2 | - AUD | 0.0% |
| 2013 Q1 | - AUD | 0.0% |
| 2012 Q1 | - AUD | 0.0% |
| 2012 FY | - AUD | 0.0% |
| 2012 Q4 | - AUD | 0.0% |
| 2012 Q3 | - AUD | 0.0% |
| 2012 Q2 | - AUD | 0.0% |
| 2011 Q4 | - AUD | 0.0% |
| 2011 Q3 | - AUD | 0.0% |
| 2011 Q2 | - AUD | 0.0% |
| 2011 Q1 | - AUD | 0.0% |
| 2011 FY | - AUD | 0.0% |
| 2010 Q1 | - AUD | 0.0% |
| 2010 Q4 | - AUD | 0.0% |
| 2010 FY | - AUD | 0.0% |
| 2010 Q3 | - AUD | 0.0% |
| 2010 Q2 | - AUD | 0.0% |
| 2009 Q2 | - AUD | -100.0% |
| 2009 Q4 | - AUD | 0.0% |
| 2009 Q1 | 91.21 Thousand AUD | 0.0% |
| 2009 FY | - AUD | -100.0% |
| 2009 Q3 | - AUD | 0.0% |
| 2008 Q4 | 91.21 Thousand AUD | 0.0% |
| 2008 Q1 | 385.85 Thousand AUD | 0.0% |
| 2008 FY | 521 Thousand AUD | -85.25% |
| 2008 Q2 | 91.21 Thousand AUD | -76.36% |
| 2008 Q3 | 91.21 Thousand AUD | 0.0% |
| 2007 Q1 | 52.17 Thousand AUD | 0.0% |
| 2007 Q3 | 385.85 Thousand AUD | 0.0% |
| 2007 FY | 3.53 Million AUD | 1589.95% |
| 2007 Q4 | 385.85 Thousand AUD | 0.0% |
| 2007 Q2 | 385.85 Thousand AUD | 639.56% |
| 2006 FY | 209 Thousand AUD | -85.28% |
| 2006 Q2 | 52.17 Thousand AUD | -85.3% |
| 2006 Q3 | 52.17 Thousand AUD | 0.0% |
| 2006 Q1 | 355 Thousand AUD | 0.0% |
| 2006 Q4 | 52.17 Thousand AUD | 0.0% |
| 2005 FY | 1.42 Million AUD | 0.0% |
| 2005 Q1 | - AUD | 0.0% |
| 2005 Q4 | 355 Thousand AUD | 0.0% |
| 2005 Q3 | 355 Thousand AUD | 0.0% |
| 2005 Q2 | 355 Thousand AUD | 0.0% |
| 2004 Q3 | - AUD | 0.0% |
| 2004 Q2 | - AUD | -100.0% |
| 2004 FY | - AUD | -100.0% |
| 2004 Q1 | 38.51 Thousand AUD | 0.0% |
| 2004 Q4 | - AUD | 0.0% |
| 2003 FY | 323 Thousand AUD | -25.75% |
| 2003 Q3 | 38.51 Thousand AUD | 0.0% |
| 2003 Q4 | 38.51 Thousand AUD | 0.0% |
| 2003 Q2 | 38.51 Thousand AUD | -64.59% |
| 2003 Q1 | 108.75 Thousand AUD | 0.0% |
| 2002 Q2 | 108.75 Thousand AUD | 0.0% |
| 2002 Q3 | 108.75 Thousand AUD | 0.0% |
| 2002 Q4 | 108.75 Thousand AUD | 0.0% |
| 2002 FY | 435 Thousand AUD | 0.0% |
| 2002 Q1 | - AUD | 0.0% |
| 2001 Q2 | - AUD | 0.0% |
| 2001 FY | - AUD | 0.0% |
| 2001 Q4 | - AUD | 0.0% |
| 2001 Q1 | - AUD | 0.0% |
| 2001 Q3 | - AUD | 0.0% |
| 2000 Q3 | - AUD | 0.0% |
| 2000 FY | - AUD | 0.0% |
| 2000 Q1 | - AUD | 0.0% |
| 2000 Q2 | - AUD | 0.0% |
| 2000 Q4 | - AUD | 0.0% |
| 1999 FY | - AUD | 0.0% |
| 1999 Q1 | - AUD | 0.0% |
| 1999 Q2 | - AUD | 0.0% |
| 1999 Q4 | - AUD | 0.0% |
| 1999 Q3 | - AUD | 0.0% |
| 1998 FY | - AUD | 0.0% |
| 1998 Q4 | - AUD | 0.0% |
| 1998 Q3 | - AUD | 0.0% |
| 1998 Q2 | - AUD | 0.0% |
| 1998 Q1 | - AUD | 0.0% |
| 1997 Q2 | - AUD | 0.0% |
| 1997 FY | - AUD | 0.0% |
| 1997 Q3 | - AUD | 0.0% |
| 1997 Q1 | - AUD | 0.0% |
| 1997 Q4 | - AUD | 0.0% |
| 1996 FY | - AUD | 0.0% |
| 1996 Q4 | - AUD | 0.0% |
| 1996 Q3 | - AUD | 0.0% |
| 1996 Q2 | - AUD | 0.0% |
| 1996 Q1 | - AUD | 0.0% |
| 1995 FY | - AUD | 0.0% |
| 1995 Q4 | - AUD | 0.0% |
| 1995 Q3 | - AUD | 0.0% |
| 1995 Q2 | - AUD | 0.0% |
| 1995 Q1 | - AUD | 0.0% |
| 1994 Q1 | - AUD | 0.0% |
| 1994 FY | - AUD | 0.0% |
| 1994 Q4 | - AUD | 0.0% |
| 1994 Q3 | - AUD | 0.0% |
| 1994 Q2 | - AUD | 0.0% |
| 1993 Q3 | - AUD | 0.0% |
| 1993 Q2 | - AUD | 0.0% |
| 1993 Q1 | - AUD | 0.0% |
| 1993 Q4 | - AUD | 0.0% |
| 1993 FY | - AUD | 0.0% |
| 1992 Q3 | - AUD | 0.0% |
| 1992 Q4 | - AUD | 0.0% |
| 1992 FY | - AUD | 0.0% |
| 1992 Q1 | - AUD | 0.0% |
| 1992 Q2 | - AUD | 0.0% |
| 1991 Q4 | - AUD | 0.0% |
| 1991 Q3 | - AUD | 0.0% |
| 1991 FY | - AUD | 0.0% |
| 1991 Q2 | - AUD | 0.0% |
| 1991 Q1 | - AUD | 0.0% |
| 1990 Q2 | - AUD | 0.0% |
| 1990 Q4 | - AUD | 0.0% |
| 1990 Q3 | - AUD | 0.0% |
| 1990 Q1 | - AUD | 0.0% |
| 1990 FY | - AUD | 0.0% |
| 1989 Q3 | - AUD | 0.0% |
| 1989 FY | - AUD | 0.0% |
| 1989 Q4 | - AUD | 0.0% |
| 1989 Q2 | - AUD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| AdAlta Limited | 1.73 Million AUD | -113.625% |
| Acrux Limited | 5.09 Million AUD | 27.08% |
| Amplia Therapeutics Limited | 4.45 Million AUD | 16.627% |
| Biome Australia Limited | 13 Million AUD | 71.463% |
| BTC Health Limited | 16.36 Thousand AUD | -22591.711% |
| Chimeric Therapeutics Limited | 7.45 Million AUD | 50.221% |
| CSL Limited | 22.41 Billion AUD | 99.983% |
| Clarity Pharmaceuticals Ltd | 11.5 Million AUD | 67.737% |
| Clinuvel Pharmaceuticals Limited | 88.17 Million AUD | 95.79% |
| Noxopharm Limited | 2.4 Million AUD | -54.664% |
| PharmAust Limited | - AUD | -Infinity% |
| Proteomics International Laboratories Limited | 892.14 Thousand AUD | -316.118% |
| PYC Therapeutics Limited | 22.05 Million AUD | 83.171% |
| Race Oncology Limited | 4 Million AUD | 7.271% |
| Starpharma Holdings Limited | 8.28 Million AUD | 55.213% |
| EZZ Life Science Holdings Limited | 66.44 Million AUD | 94.413% |
| Botanix Pharmaceuticals Limited | 601.82 Thousand AUD | -516.856% |
| Memphasys Limited | 60 Thousand AUD | -6087.273% |
| Nyrada Inc. | - AUD | -Infinity% |
| Anatara Lifesciences Ltd | - AUD | -Infinity% |
| Telix Pharmaceuticals Limited | 496.65 Million AUD | 99.253% |
| Bio-Gene Technology Limited | 18.32 Thousand AUD | -20163.996% |
| Zelira Therapeutics Limited | 94.95 Thousand AUD | -3809.727% |
| Patrys Limited | 1.39 Million AUD | -166.279% |
| Dimerix Limited | 583.47 Thousand AUD | -536.247% |
| Neuren Pharmaceuticals Limited | 231.92 Million AUD | 98.399% |
| Orthocell Limited | 5.31 Million AUD | 30.158% |
| Imugene Limited | - AUD | -Infinity% |
| Cynata Therapeutics Limited | 2.31 Million AUD | -60.317% |
| Immutep Limited | 3.5 Million AUD | -5.894% |
| Arovella Therapeutics Limited | 17 Thousand AUD | -21737.435% |
| Alterity Therapeutics Limited | 4.01 Million AUD | 7.636% |
| Nanollose Limited | 12.5 Thousand AUD | -29596.536% |
| Invex Therapeutics Ltd | 1.21 Million AUD | -206.236% |
| NeuroScientific Biopharmaceuticals Limited | - AUD | -Infinity% |
| Island Pharmaceuticals Limited | 1.25 Million AUD | -196.615% |
| Biotron Limited | - AUD | -Infinity% |
| Radiopharm Theranostics Limited | 299.22 Thousand AUD | -1140.647% |
| Tissue Repair Ltd | 152.24 Thousand AUD | -2338.494% |
| AnteoTech Limited | 460.39 Thousand AUD | -706.34% |
| Hexima Limited | - AUD | -Infinity% |
| Paradigm Biopharmaceuticals Limited | 65.8 Thousand AUD | -5541.891% |
| Recce Pharmaceuticals Ltd | - AUD | -Infinity% |
| Avecho Biotechnology Limited | 473.55 Thousand AUD | -683.942% |
| Actinogen Medical Limited | 9.93 Million AUD | 62.62% |
| Immuron Limited | 4.9 Million AUD | 24.282% |
| Argenica Therapeutics Limited | 2.59 Million AUD | -42.897% |